Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey

Journal of Inherited Metabolic Disease

Volumn 38, Issue 2, 2015, Pages 323-331

  Brands, Marion M G ^a   Güngör, Deniz ^a   van den Hout, Johanna M P ^a   Karstens, Francois P J ^a   Oussoren, Esmee ^a   Plug, Iris ^a   Boelens, Jaap Jan ^b   van Hasselt, Peter M ^c   Hollak, Carla E M ^d   Mulder, Margot F ^e   Gozalbo, Estela Rubio ^f   Smeitink, Jan A ^g   Smit, G Peter A ^h   Wijburg, Frits A ^d   Meutgeert, Hanka ⁱ   van der Ploeg, Ans T ^a,j  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

ⁱ Dutch Patient Organization for Children and Adults with Metabolic Disorders   (Netherlands)

^j SOPHIA CHILDREN S HOSPITAL   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTHRALGIA; CHILD; CHRONIC PAIN; COMPARATIVE STUDY; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DISABILITY; FEMALE; HEALTH CARE SURVEY; HUMAN; INTELLECTUAL DISABILITY; MALE; MENTAL PATIENT; MIDDLE AGED; MUCOPOLYSACCHARIDOSES; NETHERLANDS; PAIN MEASUREMENT; PRESCHOOL CHILD; PREVALENCE; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; ADULT; ARTHRALGIA; CHILD; CHILD, PRESCHOOL; CHRONIC PAIN; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; INTELLECTUAL DISABILITY; MALE; MENTALLY DISABLED PERSONS; MIDDLE AGED; MUCOPOLYSACCHARIDOSES; NETHERLANDS; PAIN MEASUREMENT; PREVALENCE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84939879622     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-014-9737-0     Document Type: Article

References (42)

1. Aaronson NK, Muller M, Cohen PD et al (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055–1068
2. Bank RA, Groener JE, van Gemund JJ, Maaswinkel PD, Hoeben KA, Schut HA, Everts V (2009) Deficiency in N-acetylgalactosamine-6-sulfate sulfatase results in collagen perturbations in cartilage of Morquio syndrome A patients. Mol Genet Metab 97:196–201
3. Bax MC, Colville GA (1995) Behaviour in mucopolysaccharide disorders. Arch Dis Child 73:77–81
4. Becker N, Bondegaard Thomsen A, Olsen AK, Sjogren P, Bech P, Eriksen J (1997) Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 73:393–400
5. Breau LM, Camfield CS, Camfield P (2010) Development and initial validation of the Batten’s observational pain scale. J Pain Manag 3:283–292
6. Breau LM, Camfield CS, McGrath PJ, Finley GA (2003) The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med 157:1219–1226
7. Breau LM, McGrath PJ, Camfield CS, Finley GA (2002) Psychometric properties of the non-communicating children’s pain checklist-revised. Pain 99:349–357
8. Burlina AP, Sims KB, Politei JM et al (2011) Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol 11:61
9. Clarke LA, Wraith JE, Beck M et al (2009) Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 123:229–240
10. de Ru MH, Boelens JJ, Das AM, et al (2011)Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 6: 55-1172-6-55.
11. de Ruijter J, Maas M, Janssen A, Wijburg FA (2013) High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study. Mol Genet Metab 109:49–53
12. Ferrari S, Ponzin D, Ashworth JL, Fahnehjelm KT, Summers CG, Harmatz PR, Scarpa M (2011) Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis. Br J Ophthalmol 95:613–619
13. Haddad FS, Jones DH, Vellodi A, Kane N, Pitt MC (1997) Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses. J Bone Joint Surg (Br) 79:576–582
14. Halbig M, Horneff G (2009) Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept. Rheumatol Int 30:229–238
15. Harmatz P, Ketteridge D, Giugliani R et al (2005) Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics 115:e681–e689
16. Haverman L, Grootenhuis MA, van den Berg JM et al (2012) Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a Web-based survey. Arthritis Care Res (Hoboken) 64:694–703
17. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B (2001) The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 93:173–183
18. Huguet A, Miro J (2008) The severity of chronic pediatric pain: an epidemiological study. J Pain 9:226–236
19. Jensen MP, Chen C, Brugger AM (2003) Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain 4:407–414
20. Kunik ME, Snow AL, Davila JA et al (2010) Causes of aggressive behavior in patients with dementia. J Clin Psychiatry 71:1145–1152
21. Kwaliteitsinstituut voor de Gezondheidszorg, CBO (2007)Richtlijn Pijnmeting en Behandeling bij pijn bij kinderen.
22. Kwon JY, Ko K, Sohn YB et al (2011) High prevalence of carpal tunnel syndrome in children with mucopolysaccharidosis type II (Hunter syndrome). Am J Med Genet A 155A:1329–1335
23. Lillegraven S, Kvien TK (2007) Measuring disability and quality of life in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 21:827–840
24. Lotan M, Ljunggren EA, Johnsen TB, Defrin R, Pick CG, Strand LI (2009) A modified version of the non-communicating children pain checklist-revised, adapted to adults with intellectual and developmental disabilities: sensitivity to pain and internal consistency. J Pain 10:398–407
25. McGrath PJ, Rosmus C, Canfield C, Campbell MA, Hennigar A (1998) Behaviours caregivers use to determine pain in non-verbal, cognitively impaired individuals. Dev Med Child Neurol 40:340–343
26. McGuire BE, Daly P, Smyth F (2010) Chronic pain in people with an intellectual disability: under-recognised and under-treated? J Intellect Disabil Res 54:240–245
27. Neufeld EF, Muenzer J et al (2001) The Mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Professional, New York, pp 3421–3452
28. Norimatsu T, Osaki M, Tomita M et al (2011) Factors predicting health-related quality of life in knee osteoarthritis among community-dwelling women in Japan: the Hizen-Oshima study. Orthopedics 34:e535–e540
29. Oussoren E, Brands MM, Ruijter GJ, der Ploeg AT, Reuser AJ (2011) Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options. Biochim Biophys Acta 1812:1542–1556
30. Pastores GM, Patel MJ, Firooznia H (2000) Bone and joint complications related to Gaucher disease. Curr Rheumatol Rep 2:175–180
31. Paul SM, Zelman DC, Smith M, Miaskowski C (2005) Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 113:37–44
32. Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, Bohnen AM, van Suijlekom-Smit LW, Passchier J, van der Wouden JC (2000) Pain in children and adolescents: a common experience. Pain 87:51–58
33. Prince FH, Geerdink LM, Borsboom GJ et al (2010) Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. Ann Rheum Dis 69:138–142
34. Scholte EM, Van Duijn G, Dijkxhoorn YM, Noens ILJ, van Berckelaer-Onnes IA (2008) Handleiding Vineland Screener 0–6 jaar. PITS, Leiden
35. Simonaro CM, D’Angelo M, Haskins ME, Schuchman EH (2005) Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res 57:701–707
36. Simonaro CM, D’Angelo M, He X, Eliyahu E, Shtraizent N, Haskins ME, Schuchman EH (2008) Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol 172:112–122
37. Simonaro CM, Ge Y, Eliyahu E, He X, Jepsen KJ, Schuchman EH (2010) Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses. Proc Natl Acad Sci U S A 107:222–227
38. Varni JW, Burwinkle TM, Seid M (2006) The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity. Qual Life Res 15:203–215
39. Varni JW, Limbers CA, Burwinkle TM (2007) Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes 5:43
40. Varni JW, Seid M, Rode CA (1999) The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 37:126–139
41. Walsh M, Morrison TG, McGuire BE (2011) Chronic pain in adults with an intellectual disability: prevalence, impact, and health service use based on caregiver report. Pain 152:1951–1957
42. Wraith JE (2009) Enzyme replacement therapy for the management of the mucopolysaccharidoses. Int J Clin Pharmacol Ther 47(Suppl 1):S63–S65